Cellular Biomedicine Opens Shanghai CAR-T Facility

02:56 EST 9 Nov 2017 | ChinaBio Today

Cellular Biomedicine held an official opening for its new Shanghai CAR-T manufacturing facility, located in Zhangjiang High-Tech Park. The company now has three China plants (Beijing, Shanghai, Wuxi), which will provide clinical trial supplies of its CAR-T candidate. In 2015, Cellular Biomedicine formed a partnership with the Chinese PLA General Hospital (the 301 hospital) of Beijing for the CAR-T immunotherapy. CBMG says it now has the ability to produce all plasmids and viral vectors for the therapy in-house. More details....

Stock Symbol: (NSDQ: CBMG)

Share this with colleagues:

Original Article: Cellular Biomedicine Opens Shanghai CAR-T Facility


More From BioPortfolio on "Cellular Biomedicine Opens Shanghai CAR-T Facility"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...